Clinical Trial Update: Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host Disease [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial comparing tacrolimus/methotrexate versus cyclosporine/methotrexate for prophylaxis of graft-versus-host disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• METHOTREXATE (METHOTREXATE)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Graft vs Host Disease | Phase 2, Phase 3 | Status: COMPLETED